Di Stasi SM - Search Results

1

Hexaminolevulinate hydrochloride in the detection of nonmuscle invasive cancer of the bladder.

Di Stasi SM, De Carlo F, Pagliarulo V, Masedu F, Verri C, Celestino F, Riedl C. Di Stasi SM, et al. Ther Adv Urol. 2015 Dec;7(6):339-50. doi: 10.1177/1756287215603274. Ther Adv Urol. 2015. PMID: 26622319 Free PMC article. Review.

2

Updates in intravesical electromotive drug administration of mitomycin-C for non-muscle invasive bladder cancer.

Di Stasi SM, Riedl C. Di Stasi SM, et al. World J Urol. 2009 Jun;27(3):325-30. doi: 10.1007/s00345-009-0389-x. Epub 2009 Feb 21. World J Urol. 2009. PMID: 19234707

3

Intravesical electromotive drug administration of mitomycin-C for non-muscle invasive bladder cancer.

Di Stasi SM, Liberati E, Dutto L, Verri C. Di Stasi SM, et al. Arch Ital Urol Androl. 2008 Dec;80(4):157-61. Arch Ital Urol Androl. 2008. PMID: 19235432 Review.

4

[Intravesical Electromotive Drug Administration®(EMDA)with Mitomycin-C for non-muscle invasive bladder cancer].

Di Stasi SM, Dutto L, Verri C. Di Stasi SM, et al. Urologia. 2008 Oct-Dec;75(4):214-20. Urologia. 2008. PMID: 21086335 Italian.

5

Electromotive instillation of mitomycin immediately before transurethral resection for patients with primary urothelial non-muscle invasive bladder cancer: a randomised controlled trial.

Di Stasi SM, Valenti M, Verri C, Liberati E, Giurioli A, Leprini G, Masedu F, Ricci AR, Micali F, Vespasiani G. Di Stasi SM, et al. Lancet Oncol. 2011 Sep;12(9):871-9. doi: 10.1016/S1470-2045(11)70190-5. Epub 2011 Aug 8. Lancet Oncol. 2011. PMID: 21831711 Clinical Trial.

6

[Intravesical therapy with mitomycin through electromotive drug administration].

Verri C, Liberati E, Celestino F, De Carlo F, Torelli F, Di Stasi SM. Verri C, et al. Among authors: di stasi sm. Urologia. 2013 Apr-Jun;80(2):105-11. doi: 10.5301/RU.2013.11290. Epub 2013 Jul 1. Urologia. 2013. PMID: 23852927 Italian.

7

Retropubic, laparoscopic, and robot-assisted radical prostatectomy: surgical, oncological, and functional outcomes: a systematic review.

De Carlo F, Celestino F, Verri C, Masedu F, Liberati E, Di Stasi SM. De Carlo F, et al. Among authors: di stasi sm. Urol Int. 2014;93(4):373-83. doi: 10.1159/000366008. Epub 2014 Sep 23. Urol Int. 2014. PMID: 25277444 Review.

8

Localised prostate cancer and hemophilia A (AHA): Case report and management of the disease.

Celestino F, Verri C, De Carlo F, Di Stasi SM. Celestino F, et al. Among authors: di stasi sm. Arch Ital Urol Androl. 2014 Sep 30;86(3):227-8. doi: 10.4081/aiua.2014.3.227. Arch Ital Urol Androl. 2014. PMID: 25308593 Free article.

9

Celecoxib for the prevention of nonmuscle invasive bladder cancer: results from a matched control study.

Pagliarulo V, Ancona P, Martines I, Spadavecchia R, Di Stasi S, Alba S, Cormio L, Fanizza C, Salerno A, Carrieri G, Pagliarulo A. Pagliarulo V, et al. Ther Adv Urol. 2015 Dec;7(6):303-11. doi: 10.1177/1756287215599695. Ther Adv Urol. 2015. PMID: 26622316 Free PMC article.

10

Intravesical electro-osmotic administration of mitomycin C.

Di Stasi SM, Verri C, Celestino F, De Carlo F, Pagliarulo V. Di Stasi SM, et al. Urologia. 2016 Oct 4;83(Suppl 2):18-23. doi: 10.5301/uro.5000202. Epub 2016 Oct 1. Urologia. 2016. PMID: 27716887 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

86 results

Search Page

Filters